title: Clinical neurology in lung transplantation.
abstract: Lung transplantation is the only established therapeutic option for several end-stage respiratory diseases. Limited mostly by lack of suitable allografts, the results have measurably improved over the last decade. Numerous surgical and pharmaceutical improvements have had positive impact on outcomes. The potential for critical care issues and the need for interdisciplinary management remains paramount. Cardiac, renal, and metabolic complications are frequently encountered in the acute postoperative phase. Allograft rejection and infectious diseases as well as problems related to immunosuppressive regimen are seen later after lung transplantation. Neurologic manifestations with a range of etiologies are discussed here in this context.
authors.affiliation: Department of Surgery, Section of Cardiac & Thoracic Surgery, University of Chicago, Chicago, IL, USA. Electronic address: cwigfield@surgery.bsd.uchicago.edu.
authors.forename: Christopher H
authors.initials: CH
authors.lastname: Wigfield
authors.affiliation: Department of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaulkee, Wi, USA.
authors.forename: Robert B
authors.initials: RB
authors.lastname: Love
mesh_terms: D006084:Graft Rejection; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016040:Lung Transplantation / Q000009:adverse effects* / Q000379:methods / Q000523:psychology; D009422:Nervous System Diseases / Q000209:etiology* / Q000503:physiopathology / Q000523:psychology; D018579:Patient Selection; D011183:Postoperative Complications / Q000503:physiopathology*; D009927:Tissue and Organ Procurement; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents
keywords: Lung transplantation; lung transplantation; nervous system; post-transplant CNS complications; post-transplant neurology